(Q40836518)

24 September 2017

1 reference

title

Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference (English)

1 reference

24 September 2017

Wheeless LL

1

1 reference

24 September 2017

Badalament RA

2

1 reference

24 September 2017

de Vere White RW

3

1 reference

24 September 2017

Fradet Y

4

1 reference

24 September 2017

Tribukait B

5

1 reference

24 September 2017

publication date

1 January 1993

1 reference

24 September 2017

number of pages

4

1 reference

inferred from page(s)

published in

Cytometry

1 reference

24 September 2017

volume

14

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

478-481

1 reference

The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

Flow cytometric evaluation of bladder cancer: recommendations of the NCI flow cytometry network for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Flow cytometric analysis of primary and metastatic bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Flow cytometry: role in monitoring transitional cell carcinoma of bladder

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

The Predictive Value of Flow Cytometry and Urinary Cytology in the Followup of Patients with Transitional Cell Carcinoma of the Bladder

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Characterization of bladder carcinomas by flow DNA analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

The prognostic value of DNA analysis in primary carcinoma in situ of the urinary bladder

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

DNA profile and tumour progression in patients with superficial bladder tumours

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Detection of bladder carcinoma in females by flow cytometry and cytology

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Deoxyribonucleic Acid Flow Cytometry in Invasive Bladder Carcinoma: A Possible Predictor for Successful Bladder Preservation following Transurethral Surgery and Chemotherapy-Radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Flow cytometric study comparing paired bladder washing and voided urine for bladder cancer detection

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Predictive value of DNA measurements in bladder washings. Comparison of flow cytometry, image cytophotometry, and cytology in patients with a past history of urothelial tumors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Comparative flow cytometric deoxyribonucleic acid studies on exophytic tumor and random mucosal biopsies in untreated carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Deoxyribonucleic acid profile and tumor progression in primary carcinoma in situ of the bladder: a study of 63 patients with grade 3 lesions

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Prognostic significance of mucosal aneuploidy in stage Ta/T1 grade 3 carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Precision of DNA flow cytometry in inter-institutional analyses

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Urine or bladder washings in the cytologic evaluation of transitional cell carcinoma of the urinary tract. A comparison made under routine conditions supplemented by flow cytometric DNA analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Deoxyribonucleic acid flow cytometry in predicting response to radical radiotherapy of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

DNA Analysis in Predicting Survival of Irradiated Patients with Transitional Cell Carcinoma of Bladder

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140504

7 January 2021

Identifiers

DOI

10.1002/CYTO.990140504

1 reference

24 September 2017

1 reference